AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

AI is reshaping labs and Clever Culture’s tech is gaining Big Pharma attention as diagnostics and cleanrooms go digital.

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech announced their first commercial lab, a preclinical startup space within the Massachusetts Biomedical Initiatives (MBI) facility in ...

reflects the changing nature of the biotech’s relationship with Vertex regarding Casgevy. The outlook may be improving as CRISPR’s stock has gained 30% from the lows it hit earlier this ...

You can reach Adam on Signal at stataf.54. Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter. New this quarter, we’re tracking a ...

So, the biotech likely won't get acquired in the next year. If its shares soar, it won't be for that reason. Could other catalysts send Viking Therapeutics' stock through the roof? Whether Viking ...

Most biotech stocks aren't great picks for investors to buy and hold forever. But Vertex Pharmaceuticals is an exception. The Motley Fool Stock Advisor analyst team just identified what they ...

Mizuho is bullish on the stock of Neumora Therapeutics Inc., which is developing a promising treatment for major depressive disorder. Photo: Getty Images/iStockphoto ...

The reason for the stock's rapid ascent is a mystery. Biotech stocks can be incredibly attractive for risk-taking investors because of their ability to go parabolic in an instant. Whether it's a ...

VKTX's earlier bounce off the $70 level came short of a familiar ceiling at $80, but the 20-day moving average lingers below as support. Shares sport a jaw-dropping 571.8% year-over-year lead ...